Compare EYE & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EYE | PRGO |
|---|---|---|
| Founded | 1990 | 1887 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.8B |
| IPO Year | 2017 | 2013 |
| Metric | EYE | PRGO |
|---|---|---|
| Price | $19.20 | $12.94 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 3 |
| Target Price | ★ $31.22 | $19.33 |
| AVG Volume (30 Days) | 2.1M | ★ 3.0M |
| Earning Date | 05-13-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 10.28% |
| EPS Growth | ★ 202.78 | N/A |
| EPS | ★ 0.54 | N/A |
| Revenue | ★ $1,987,488,000.00 | $800,000.00 |
| Revenue This Year | $5.56 | N/A |
| Revenue Next Year | $6.58 | $1.02 |
| P/E Ratio | $50.13 | ★ N/A |
| Revenue Growth | ★ 9.00 | N/A |
| 52 Week Low | $14.75 | $9.23 |
| 52 Week High | $30.02 | $24.61 |
| Indicator | EYE | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 36.06 | 65.56 |
| Support Level | $14.84 | $12.45 |
| Resistance Level | $19.18 | $13.89 |
| Average True Range (ATR) | 0.96 | 0.51 |
| MACD | -0.47 | 0.19 |
| Stochastic Oscillator | 5.66 | 76.99 |
National Vision Holdings Inc. is an optical retailer in the United States. Its product portfolio includes eyeglasses, sunglasses, contact lenses, accessories, and other related products. The company operates through a single operating segment. The Owned and Host segment includes the company-owned brands America's Best and Eyeglass World. In America's Best stores, vision care services are provided by optometrists or by independent professional corporations. The Host segment consists of Military and Fred Meyer locations, where eye exams are provided by independent optometrists.
Perrigo is a pure-play consumer healthcare product manufacturer and distributor. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. It plays in a number of over-the-counter categories including pain, skincare, women's health, and nutrition. Perrigo also competes in Europe, Australia, and parts of Asia, where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.